Codadose Inc.

Musculoskeletal and Connective Tissue Disorders

Codadose Inc. is involved in clinical research related to musculoskeletal disorders and connective tissue conditions, with a focus on therapies used in pain-associated inflammatory settings.

  • Musculoskeletal pain
  • Connective tissue disorders
  • Anti-inflammatory therapy

The sponsor’s research activity in this area reflects interest in treatment options relevant to everyday pain management and disorders affecting joints, soft tissues, and supporting connective structures.

Acute Pain

The clinical portfolio includes acute pain, indicating attention to short-term analgesic treatment and symptom control in adult populations.

  • Analgesic therapy
  • Short-term pain relief
  • Oral pain medications

This area aligns with research into medicines used for rapid relief of painful episodes, including conditions where pain intensity and onset of action are clinically important.

Dysmenorrhea

Codadose Inc. also studies dysmenorrhea, a women’s health condition associated with menstrual pain and functional discomfort.

  • Menstrual pain
  • Women’s health
  • Symptomatic pain management

Research in this domain supports evaluation of therapies intended to address cramping and pain linked to the menstrual cycle.

Pharmacokinetics and Bioavailability

The sponsor’s trial activity includes assessment of pharmacokinetic behavior and bioavailability for an oral celecoxib formulation, with interest in how the medicine is absorbed and processed in the body.

  • Oral suspension formulations
  • Comparative bioavailability
  • Food effect evaluation

This focus highlights therapeutic development around nonsteroidal anti-inflammatory treatment options and formulation performance in healthy adult volunteers.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • A study to compare how the body absorbs celecoxib oral suspension and celecoxib capsules in healthy adults for the treatment of acute pain.

    Not recruiting

    1 1 1
    Investigated drugs:
    Czechia